I recently shared a BMJ report that outlined the approval of Esketamine in Europe: Since sharing this news, the following rapid response by the MHRA [The Medicines and Healthcare products … Continue reading Esketamine: Regulators and a confusing narrative
The BMJ has published this News report, the full article can be accessed here.
The above editorial “What is treatment resistance in Psychiatry?” features in the current edition of World Psychiatry and has generated considerable discussion on social media. Ten months ago this “News” … Continue reading “What is treatment resistance in Psychiatry?”
Last month I shared a BMJ Editorial on Ketamine by Dr Sameer Jauhar and Dr Paul Morrison. Since then there have been a number of published BMJ responses and replies. … Continue reading Ketamine: “lost in translation?”
There has long been awareness of the effects of Ketamine use among those who have taken it unprescribed. Given the lack of long term data on this specific “new therapeutic … Continue reading “We should cautiously welcome this new therapeutic option”
As a Member of the Royal College of Psychiatrists I have received an invitation to the Autumn Meeting of the Royal College of Psychiatrists in Scotland. This is to be … Continue reading Surgeon’s Hall: ‘Improving our understanding and treatment of depression’